Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,521Revenue $M523Net Margin (%)12.0Altman Z-Score4.2
Enterprise Value $M1,461EPS $1.2Operating Margin %18.4Piotroski F-Score6
P/E(ttm)31.3Beneish M-Score-1.2Pre-tax Margin (%)17.2Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %5.0Quick Ratio4.6Cash flow > EarningsN
Price/Sales3.45-y EBITDA Growth Rate %8.2Current Ratio5.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %22.6ROA % (ttm)6.5Higher Current Ratio y-yY
Dividend Yield %--PEG4.0ROE % (ttm)10.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M39.5ROIC % (ttm)11.8Gross Margin Increase y-yY

Gurus Latest Trades with EBS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EBSJoel Greenblatt 2015-12-31 Buy 0.19%$28.34 - $40.28
($35.09)
$ 38.5210%New holding446,867
EBSKen Fisher 2015-12-31 Reduce$28.34 - $40.28
($34.97)
$ 38.5210%Reduce -0.19%457,742
EBSKen Fisher 2015-09-30 Reduce$28.49 - $35.63
($32.99)
$ 38.5217%Reduce -0.82%458,634
EBSKen Fisher 2015-06-30 Reduce$28.76 - $33.69
($30.97)
$ 38.5224%Reduce -7.78%462,428
EBSJoel Greenblatt 2014-09-30 Sold Out -0.06%$21.31 - $24.9
($22.93)
$ 38.5268%Sold Out0
EBSJoel Greenblatt 2014-03-31 Buy 0.1%$22.85 - $28.09
($25.19)
$ 38.5253%New holding258,760
EBSJohn Rogers 2014-03-31 Sold Out -0.04%$22.85 - $28.09
($25.19)
$ 38.5253%Sold Out0
EBSJohn Rogers 2013-12-31 Add0.02%$17.71 - $23.95
($20.84)
$ 38.5285%Add 105.79%122,650
EBSJohn Rogers 2013-09-30 Add0.01%$15.22 - $19.43
($17.88)
$ 38.52115%Add 116.73%59,600
EBSJohn Rogers 2013-06-30 Buy 0.01%$13.08 - $15.73
($14.48)
$ 38.52166%New holding27,500
EBSJoel Greenblatt 2013-03-31 Sold Out -0.14%$13.95 - $16.9
($15.67)
$ 38.52146%Sold Out0
EBSJoel Greenblatt 2012-12-31 Buy 0.14%$12.91 - $16.09
($14.64)
$ 38.52163%New holding147,099
EBSKen Fisher 2012-12-31 Add$12.91 - $16.09
($14.64)
$ 38.52163%Add 21.09%401,700
EBSJoel Greenblatt 2011-12-31 Sold Out -0.08%$15.43 - $19.64
($17.41)
$ 38.52121%Sold Out0
EBSJoel Greenblatt 2011-06-30 Reduce-0.05%$20.66 - $24.98
($23.2)
$ 38.5266%Reduce -20.74%26,620
EBSKen Fisher 2011-06-30 Add0.01%$20.66 - $24.98
($23.2)
$ 38.5266%Add 160.57%300,305
EBSJoel Greenblatt 2011-03-31 Add0.17%$20.64 - $24.55
($22.62)
$ 38.5270%Add 243.58%33,585
EBSKen Fisher 2011-03-31 Buy 0.01%$20.64 - $24.55
($22.62)
$ 38.5270%New holding115,250
EBSJoel Greenblatt 2010-12-31 Buy 0.07%$17.59 - $23.8
($19.23)
$ 38.52100%New holding9,775
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EBS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
El-Hibri FuadChairman, 10% Owner 2016-04-22Sell4,209$40.5-4.89view
Abdun-Nabi DanielPresident & CEO 2016-04-18Sell8,702$40.17-4.11view
El-Hibri FuadChairman, 10% Owner 2016-04-18Sell20,791$40.5-4.89view
Kramer RobertEVP, Corporate Services Divisi 2016-04-06Sell21,786$38.9-0.98view
El-Hibri FuadChairman, 10% Owner 2016-04-06Sell50,000$39-1.23view
Kramer RobertEVP, Corporate Services Divisi 2016-04-04Sell21,788$36.94.39view
Kramer RobertEVP, Corporate Services Divisi 2016-04-01Sell43,572$35.568.32view
Hauer Jerome MDirector 2016-03-14Sell2,350$33.8813.7view
Havey AdamEVP, Biodefense Divison 2016-03-14Sell4,359$33.9613.43view
SULLIVAN LOUIS WDirector 2016-03-11Sell14,879$34.0313.19view

Press Releases about EBS :

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource Jan 03 2016 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Aug 06 2010 
Emergent BioSolutions Inc. (EBS) President & COO Daniel Abdun-nabi sells 18,150 Shares Jul 30 2010 
Weekly CEO Sells Highlight: Yum! Brands Inc, Marchex Inc, iGate Corp, and Emergent BioSolutions Inc. Jul 25 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 18,800 Shares Jul 23 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 130,100 Shares Jul 22 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 84,433 Shares Jul 19 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 52,000 Shares May 14 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) May 06 2010 

More From Other Websites
5 Sturdy Stocks to Play Weakest Growth in 2 Years Apr 29 2016
Erste Bank Sells Interests in Hotels Apr 28 2016
Opening: Erste Advisory Center in Sievering, Vienna Apr 28 2016
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International,... Apr 27 2016
Erste Bank: New Head of Retail Austria Division Apr 27 2016
Emergent Biosolutions to Participate in the Bank of America Merrill Lynch Healthcare Conference in... Apr 26 2016
Emergent Biosolutions to Participate in the Bank of America Merrill Lynch Healthcare Conference in... Apr 26 2016
5 Stocks to Invest on Healthcare Rebound Apr 26 2016
Top 5 Stocks with Increasing Cash Flows Apr 25 2016
Emergent BioSolutions to Release First Quarter 2016 Financial Results and Conduct a Conference Call... Apr 21 2016
Emergent BioSolutions to Release First Quarter 2016 Financial Results and Conduct a Conference Call... Apr 21 2016
Evolent Health awards executive bonuses following debut on NYSE Apr 21 2016
Erste Bank und Sparkassen Group posts operating earnings of EUR 864.6 m. Apr 21 2016
Evolent Health awards executive bonuses following debut on Nasdaq Apr 21 2016
Wizz Air is newest major tenant in Erste Group Immorent’s Laurus Offices in Budapest Apr 21 2016
Emergent BioSolutions Presents Preclinical Data on ES425 a Bispecific Immunotherapeutic Protein for... Apr 20 2016
Emergent BioSolutions Presents Preclinical Data on ES425 a Bispecific Immunotherapeutic Protein for... Apr 20 2016
Erste Group and Austrian savings banks to tender their media account Apr 19 2016
Emergent Biosolutions Reveals sBLA Submission To FDA To Make BioThrax In Building 55 Apr 18 2016
Emergent BioSolutions Submits sBLA for FDA Approval of Large-Scale Manufacturing of BioThrax in... Apr 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)